Cimadamore A, Lopez-Beltran A, Cheng L, Montironi R, et al. Re: George J. Netto, Mahul B. Amin, Eva M. Comperat, et al. Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.0 Eur Urol 2023;83:e84-e86.
PMID: 36517350